First Grant Leads to HPV Vaccine
Anna R Giuliano, PhD
Director of Cancer Prevention
H. Lee Moffitt Cancer Center
In 1991, I was a young scientist who received my first research grant from the Prevent Cancer Foundation for my study of the human papillomavirus (HPV). This award enabled me to establish the methodology for measuring the HPV DNA infection. The lessons learned gave me the ability to propose and develop the trials of the first FDA-approved vaccine against HPV, the one you’ve heard so much about in the news.
Cervical cancer was once one of the deadliest cancers affecting women in the United States, but today lives are saved because more women are routinely screened for cervical cancer. Now we have a vaccine that can prevent up to 70 percent of cervical cancer cases and it is recommended for girls and women aged 9 to 26.
Editor’s Note: This post is part of the 25th Anniversary Testimonials Initiative.